Page 23 - American Society For Transplantation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CAR-T Therapy: Combating Cytokine Release Syndrome

CAR-T Therapy: Combating Cytokine Release Syndrome Sponsored Content by ACROBiosystemsMay 21 2021 CAR-T cell therapy offers the hope of a cure to a number of cancer patients. Yet, in spite of the great effectiveness, more attention has been paid to the toxicity of the therapy known as cytokine release syndrome (CRS). This article is aimed at summarizing the main points of assessment, grading and management of CRS in CAR-T Therapy and provide answers to the following questions: How to identify the onset of CRS clinically? What is CRS management? How to use tocilizumab in CRS management？ Assessment, grading and management of CRS in CAR-T therapy

United statesMichel sadelainSloan kettering cancer centerSociety for immunotherapy of cancerCell engineering centerChinese academy of medical sciencesAmerican society for transplantationSponsored contentCombating cytokine releaseAmerican societyCell therapyScience immunologyChinese academyLabeled humanHis tagLabeled monoclonal

Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial

Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

South koreaLanguedoc roussillonUnited statesIndian moNaresh trehanSara dugganRoche products india pvt ltdNational cancer instituteMinistry of healthMedanta institute of educationAmerican society for transplantationCentral drugs standard control organisationHealth servicesemr divisionResearch indiaNational early warning scoreIndian ministry of health

CAR-T Therapy: Syndrome Released by Cytokine

CAR-T Therapy: Syndrome Released by Cytokine
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.

United statesMichel sadelainSociety for immunotherapy of cancerChinese academy of medical sciencesAmerican society for transplantationSponsored contentSyndrome releasedAmerican societyCell therapyScience translational medicineCell engineering centerSloan kettering cancerChinese academyMedical sciencesScience immunologyLabeled human

The Impact of COVID-19 on Oncology Pharmacy and Patient Care, Part 1

Medication reconciliation is a critical component of the oncology pharmacistʼs duties that has been performed safely over the phone with the patient, caregiver, and pharmacy with the assistance of electronic health records.

United statesAmerican society of clinical oncologyMayo clinic college of medicineMd anderson cancer centerUniversity of kentucky healthcare in lexingtonM health fairviewAmerican society for transplantationAmerican society of hematologyAmerican society for radiation oncologySociety of surgical oncologyEuropean society for medical oncologyNational comprehensive cancer networkAmerican societyClinical oncologyEuropean societyMedical oncology

Angiocrine Bioscience Announces Oral Presentation of Intravenous AB-205 Data during the Annual Transplantation & Cellular Therapy Meetings of ASCT and CIBMTR

Share this article Share this article SAN DIEGO, Feb. 5, 2021 /PRNewswire/ Angiocrine Bioscience Inc., a clinical-stage biopharmaceutical company today announced that the American Society for Transplantation and Cellular Therapy (ASTCT) and the Center for International Blood & Marrow Transplant Research (CIBMTR) has selected Angiocrine s AB-205 Phase 1b/2 study results for an oral presentation. Intravenous AB-205 is being developed to treat diffuse damage of vascular niches of multiple organs caused by off-target cytotoxicity from high-dose chemotherapy (HDT) in the course of conditioning patients undergoing autologous hematopoietic cell transplantation to effect a cure of aggressive lymphomas. Treating the damaged vascular niches enable prompt repair of multiple organs. In case of HDT, the most severely and frequently affected organ systems are oral-gastrointestinal and hematopoietic. By enabling multi-organ repair, AB-205 has the potential of substantially reducing the inci

United statesLihua buddeJohnr jaskowiakPaul finneganAngiocrine biosciencePrnewswire angiocrine bioscience incDrug administrationAngiocrine bioscience incAmerican society for transplantationInternational blood marrow transplant researchBioscience incAmerican societyCellular therapyInternational bloodMarrow transplant researchOral abstract